AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 492827
Drug: Pediatric telephone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pediatric telephone protocols administered by health assistants
Trial: 25818032
Drug: Instillation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Instillation of 5 ml 2% lidocaine gel in the urethra 5 minutes before catheterization
Trial: 25818032
Drug: Lubrication of
RxNorm normalized name: Eyes Alive Lubricating
DrugBank: Carboxymethylcellulose (DB11059)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lubrication of the distal part of the catheter with 5 ml 2% lidocaine gel
Trial: 11207991
Drug: Albumin infusion
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin infusion (1 g/kg bodyweight, i.v., during the first 2 h of phototherapy)
Trial: 7912393
Drug: Molsidomine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine (1 mg/h intravenously for 48 h, followed by 16 mg molsidomine by mouth daily for 12 days)
Trial: 7912393
Drug: Placebo (identical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (identical to molsidomine treatment)
Trial: 31866092
Drug: Salvage Radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salvage Radiation Therapy (SRT) ± Salvage Hormone Therapy (SHT) (64.8 Gy of SRT followed by 80 mg bicalutamide and LHRH agonist if BCL fails)
Trial: 31866092
Drug: Salvage Hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salvage Hormone Therapy (SHT) (80 mg bicalutamide followed by LHRH agonist in case of BCL failure)
Trial: 29116013
Drug: Dexamethasone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (40 mg intravenous injection)
Trial: 21449786
Drug: Double placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double placebo (placebo injection plus childhood oral placebo)
Trial: 21449786
Drug: Estrogen alone
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen alone (placebo injection plus childhood oral low-dose estrogen)
Trial: 21449786
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone alone (growth hormone injection plus childhood oral placebo)
Trial: 21449786
Drug: Growth hormone-estrogen
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone-estrogen (growth hormone injection plus childhood oral low-dose estrogen)
Trial: 21449786
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone treatment (vs. placebo)
Trial: 21449786
Drug: Growth hormone-estrogen
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone-estrogen vs. growth hormone alone
Trial: 12560406
Drug: Creatine monohydrate
RxNorm normalized name: Creatine Monohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine monohydrate (5 g/d + 2 g of dextrose)
Trial: 12560406
Drug: Placebo (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (7 g of dextrose)
Trial: 11192131
Drug: Amprenavir (APV)
DrugBank: Amprenavir (DB00701)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Amprenavir (APV) in combination with 2 nucleoside reverse transcriptase inhibitors
Trial: 9098860
Drug: Stimulation with
RxNorm normalized name: INM-005 (PURIFIED FAB'2 FRACTION OF EQUINE HYPERIMMUNE SERUM GENERATED FROM ANTIGENIC STIMULATION WITH THE SARS-COV2 RBD PROTEIN)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulation with 0.05 TU/mL of PPD
Trial: 8513853
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg diclofenac
Trial: 3912335
Drug: Nimesulide 200
RxNorm normalized name: nimesulide 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide 200 mg suppositories
Trial: 3912335
Drug: Diclofenac 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 100 mg suppositories
Trial: 23982988
Drug: 12-week exercise
RxNorm normalized name: risedronate
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12-week exercise therapy
Trial: 21354934
Drug: 0.4 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg/kg pentazocine with 1.5 mg/kg propofol
Trial: 21354934
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg pentazocine with 1.5 mg/kg propofol
Trial: 18720001
Drug: Melatonin 3
RxNorm normalized name: melatonin 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 3 mg daily for 30 days
Trial: 18720001
Drug: Melatonin 3
RxNorm normalized name: melatonin 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 3 mg daily for 8 weeks
Trial: 17288677
Drug: Sertraline 50-200
RxNorm normalized name: sertraline 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline 50-200 mg/day
Trial: 12010156
Drug: Mandibular implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandibular implants
Trial: 12010156
Drug: Maxillary implants
RxNorm normalized name: Artemisia capillaris leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maxillary implants
Trial: 9393427
Drug: Implants in
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implants in bone quality 1
Trial: 9393427
Drug: Implants in
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implants in bone quality 2
Trial: 9393427
Drug: Implants in
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implants in bone quality 3
Trial: 9393427
Drug: Implants in
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implants in bone quality 4
Trial: 7683190
Drug: High lipase
RxNorm normalized name: lipase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High lipase preparation
Trial: 282003
Drug: Simultaneous administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simultaneous administration of cytosine arabinoside (Ara-C) 150 mg/m2 and methotrexate (MTX) 40 mg/m2
Trial: 282003
Drug: Sequential administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential administration of cytosine arabinoside (Ara-C) 150 mg/m2 and methotrexate (MTX) 40 mg/m2
Trial: 28243855
Drug: BIS-based propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: BIS-based propofol dosing
Trial: 28243855
Drug: LBW-based propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: LBW-based propofol dosing
Trial: 28243855
Drug: BIS-based and
RxNorm normalized name: bis-ethoxydiglycol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIS-based and LBW-based propofol dosing
Trial: 25844841
Drug: Low-dose infliximab
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose infliximab (3.5 mg/kg)
Trial: 25844841
Drug: Standard-dose infliximab
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Standard-dose infliximab (5 mg/kg)
Trial: 15174219
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen (HBO) therapy
Trial: 23820795
Drug: Intratympanic (IT)
RxNorm normalized name: ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intratympanic (IT) steroid injection
Trial: 17159456
Drug: Olanzapine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (8 weeks treatment)
Trial: 9763328
Drug: Scaling and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling and root planing and oral hygiene combined with local controlled drug delivery with tetracycline fibers
Trial: 9763328
Drug: Scaling and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling and root planing with oral hygiene instructions
Trial: 7875182
Drug: meperidine 2
RxNorm normalized name: meperidine 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: meperidine 2 mg.kg‐1 (M)
Trial: 7875182
Drug: meperidine 2
RxNorm normalized name: meperidine 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: meperidine 2 mg.kg‐1 plus midazolam 0.05 mg.kg‐1 (M + M)
Trial: 28012181
Drug: 5-aminolaevulinic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-aminolaevulinic acid (ALA) photodynamic therapy (PDT)
Trial: 18594954
Drug: Heroin-assisted treatment
RxNorm normalized name: heroin
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heroin-assisted treatment
Trial: 21820084
Drug: JTE-607 (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JTE-607 (0.1 mg/kg/h)
Trial: 21820084
Drug: JTE-607 (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JTE-607 (0.3 mg/kg/h)
Trial: 21820084
Drug: JTE-607 (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JTE-607 (0.03 mg/kg/h)
Trial: 18075221
Drug: Dressing containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dressing containing 800 mg of plant sterol (PS), 15 g daily for 12 weeks
Trial: 17076934
Drug: tiapride (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tiapride (300 mg/d)
Trial: 15049438
Drug: Levosulpiride preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosulpiride preparation 1 (25 mg)
Trial: 15049438
Drug: Levosulpiride preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosulpiride preparation 2 (25 mg)
Trial: 8236072
Drug: PEF measurement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEF measurement at two hourly intervals during waking hours for one week
Trial: 8236072
Drug: Bronchial challenge
RxNorm normalized name: MANNITOL BRONCHIAL CHALLENGE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchial challenge test measuring the provocative dose of methacholine producing a 20% fall in FEV1 (PD20)
Trial: 3323648
Drug: i.v. immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. immunoglobulin G
Trial: 31862532
Drug: Hospitals should
RxNorm normalized name: Head & Shoulders
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospitals should provide smoking cessation treatments
Trial: 29473353
Drug: Combination group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination group (acupuncture at five mind points + modified kidney qi decoction)
Trial: 23856331
Drug: AS03-adjuvanted split
RxNorm normalized name: AS03 Adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AS03-adjuvanted split virion vaccine (3.75 μg HA/AS03)
Trial: 23856331
Drug: Non-adjuvanted vaccine
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-adjuvanted vaccine (15 μg HA)
Trial: 18386547
Drug: etoricoxib 180
RxNorm normalized name: étoricoxib
DrugBank: Etoricoxib (DB01628)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etoricoxib 180 mg
Trial: 18386547
Drug: etoricoxib 120
RxNorm normalized name: etoricoxib 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etoricoxib 120 mg and 180 mg
Trial: 11129710
Drug: Bio-Skincare (BSC)
RxNorm normalized name: Bio-Kool
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bio-Skincare (BSC) - 1.2 g
Trial: 11129710
Drug: Mosiguard towelletes
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mosiguard towelletes with 0.574 g PMD
Trial: 11129710
Drug: Deet (15%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deet (15% diethyl-3-methylbenzamide, Tabard lotion) - 0.5 g
Trial: 8770963
Drug: Magnesium carbonate
RxNorm normalized name: Magnesium Carbonate
DrugBank: Magnesium carbonate (DB09481)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Magnesium carbonate (MgCO3) at a dose of 465 +/- 52 mg/day elemental Mg
Trial: 8770963
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (CaCO3) at the usual dose
Trial: 2857677
Drug: Somatostatin infusion
RxNorm normalized name: somatostatin
DrugBank: Somatostatin (DB09099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin infusion for 72 hours
Trial: 30785624
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy for BDD (CBT‐BDD)
Trial: 16089135
Drug: Conventional medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional medicine plus tongxinluo capsule (TXL)
Trial: 16089135
Drug: Conventional medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional medicine (Control Group)
Trial: 10084583
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg oral estradiol daily
Trial: 10084583
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg oral estradiol daily
Trial: 31847908
Drug: 0.1% topical
RxNorm normalized name: Halog 0.1% Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% topical sirolimus applied for 12 weeks
Trial: 31847908
Drug: Topical vehicle
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical vehicle applied for 12 weeks
Trial: 26265727
Drug: Efalex Active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Efalex Active 50+ (1g DHA, 160 mg eicosapentaenoic acid, 240 mg Ginkgo biloba, 60 mg phosphatidylserine, 20mg d‐α tocopherol, 1mg folic acid, and 20 µg vitamin B12 per day)
Trial: 22522786
Drug: Muscle strengthening
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Muscle strengthening exercises (performed twice a week for 3 months, starting at 60% of 1MR and progressing to 85%)
Trial: 15159711
Drug: Best practices
RxNorm normalized name: calcium polycarbophil
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Best practices including assessment of arterial oxygenation, collection of blood cultures, timely initiation of appropriate empiric antibiotic therapy
Trial: 10211597
Drug: PEIT-1 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEIT-1 (1 session with a single intranodular injection of sterile 98% ethanol)
Trial: 10211597
Drug: PEIT-3 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEIT-3 (3 weekly sessions with 1 injection of sterile 98% ethanol)
Trial: 7623249
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment with gingival flap surgery with barrier membrane alone
Trial: 2533041
Drug: Ponalrestat (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ponalrestat (600 mg single dose)
Trial: 779058
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg tilidine hydrochloride
Trial: 28121722
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg of EPA and 400 mg of DHA per day for 18 weeks
Trial: 28121722
Drug: Soybean oil
RxNorm normalized name: Soybean Oil
DrugBank: Soybean oil (DB09422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soybean oil capsules (placebo) per day for 18 weeks
Trial: 9748131
Drug: 3F8 treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3F8 treatment
Trial: 9919895
Drug: Itraconazole 100
RxNorm normalized name: itraconazole 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 100 mg daily for 2 weeks
Trial: 2493756
Drug: Cromolyn sodium
RxNorm normalized name: Cromolyn Sodium
DrugBank: Cromoglicic acid (DB01003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cromolyn sodium (2 mg per dose) by MDI
Trial: 1097921
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment at placebo points
Trial: 30045159
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of PDC and GC adherence
Trial: 23219310
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 500mg orally twice daily for 28 days
Trial: 9418642
Drug: Intraarterial chemotherapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarterial chemotherapy, local irradiation, limb salvage surgery, prophylactic whole lung irradiation
Trial: 9418642
Drug: Histologic response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Histologic response to preoperative multidisciplinary therapy
Trial: 31713082
Drug: Dextrose injection
RxNorm normalized name: Dextrose Injection
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextrose injection (1% lidocaine with 20% dextrose, 1 mL)
Trial: 31713082
Drug: Saline injection
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline injection (1% lidocaine with saline, 1 mL)
Trial: 28029114
Drug: 400 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 µg folic acid and 500 µg vitamin B12 supplementation
Trial: 25011384
Drug: Combination exercise
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination exercise group
Trial: 11563205
Drug: In-home assessment
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: In-home assessment with individualized treatment plan including exercise program
Trial: 11563205
Drug: In-home assessment
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: In-home assessment with individualized treatment plan including exercise program (for subjects with more than 2 falls in the 3 months preceding study entry)
Trial: 3043949
Drug: Isoconazole cream,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoconazole cream, solution, and spray (once or twice daily)
Trial: 27670154
Drug: Daily dose
RxNorm normalized name: LENVIMA 8mg Daily Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily dose of cholecalciferol (400 IU)
Trial: 27670154
Drug: Single high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single high-dose cholecalciferol (50,000 IU)
Trial: 21477053
Drug: Sex under
RxNorm normalized name: Depend Fresh Protection Maximum Absorbency with Tabs Unisex Underwear (Large)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sex under the influence of drugs or alcohol
Trial: 21477053
Drug: No influence
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No influence of drugs or alcohol
Trial: 19055791
Drug: 0.8 mg
RxNorm normalized name: biotin 0.8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 mg oral salmon calcitonin (sCT) morning dose at 8:00
Trial: 19055791
Drug: 0.8 mg
RxNorm normalized name: biotin 0.8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 mg oral salmon calcitonin (sCT) pre-dinner dose at 17:00
Trial: 19055791
Drug: 0.8 mg
RxNorm normalized name: biotin 0.8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 mg oral salmon calcitonin (sCT) evening dose at 22:00
Trial: 11887831
Drug: Estrogen therapy
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen therapy and SERMs (raloxifene)
Trial: 8077324
Drug: Low insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low insulin infusion (742 +/- 212 pmol/L)
Trial: 8077324
Drug: High insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High insulin infusion (3360 +/- 710 pmol/L)
Trial: 8077324
Drug: Both insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Both insulin infusions
Trial: 3608350
Drug: Torasemide (intermediate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Torasemide (intermediate dose between 10 and 20 mg)
Trial: 3608350
Drug: Probenecid pretreatment
RxNorm normalized name: Probenecid
DrugBank: Probenecid (DB01032)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Probenecid pretreatment with Torasemide 20 mg
Trial: 30299202
Drug: TCZ-SC qw
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCZ-SC qw monotherapy
Trial: 23701202
Drug: Coadministration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coadministration of CQ (600 mg on days 1-2, 300 mg on day 3) and TQ (450 mg on days 2 and 3)
Trial: 23701202
Drug: TQ alone
RxNorm normalized name: TQS-168
DrugBank: TQS-168 (DB18108)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TQ alone (450 mg on days 2 and 3)
Trial: 23701202
Drug: CQ alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CQ alone (600 mg on days 1-2, 300 mg on day 3)